transferred on share sale and purchase date from the seller’s connected persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging
. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator in skin cares and cosmetics. In addition
international sales declined dramatically at 46.03% compared to the same period of the previous year. One of the issues was the delayed product delivery after the license was issued from China Food and Drug
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures
, e.g., supermarket, food and restaurants (only for takeaway), drug stores. Online sales continued to grow remarkably by 150.0% YoY. Gross profit margin from sale of goods improved outstandingly to
company has successfully raised the funding through its initial public offering of "JFin Coin" or "Initial Coin Offering" in the amount of 100 million tokens at a price of 6.60 baht per token. JVC has
company has successfully raised the funding through its initial public offering of "JFin Coin" or "Initial Coin Offering" in the amount of 100 million tokens at a price of 6.60 baht per token. JVC has
Company has raised fund from SET whereas , during 2017, the Company has spent this fund on debt repayment as well as renovation and expansion projects. However, the Company’s trade receivable Financial
decrease in Gross Profit Margin was from appreciation of Baht against other currencies causing lower revenue and gross profit although the company raised sales volume. For the three-month period ended 31